Bill Information > HB 2356
Search for another bill:
HB 2356 - 2017-18
Concerning stem cell therapies not approved by the United States food and drug administration.
See Bill History for complete details on the bill
1st Substitute - SHB 2356
Where is it in the process?
2018 REGULAR SESSION
Prefiled for introduction.
First reading, referred to Health Care & Wellness (Not Officially read and referred until adoption of Introduction report). (View Original Bill)
Public hearing in the House Committee on Health Care & Wellness at 10:00 AM. (Committee Materials)
Executive action taken in the House Committee on Health Care & Wellness at 1:30 PM. (Committee Materials)
For a complete list of documents, go to Online Reports Text of a Legislative Document.